This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance.
Cell reports · 2019
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation.
Cell metabolism · 2015
Latest funding
- $20,000
10th international conference on AMPK: From mechanisms to new therapies
CIHR · 2018 · Co-investigator
- $135,000
Investigating the role of cellular metabolism in effector T cell responses and T cell exhaustion
CIHR · 2018 · Supervisor
- $837,675
Investigating LKB1-mediated inflammation as a mediator of tumour progression
CIHR · 2017 · Nominated PI
2 publications.
The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance.
El-Houjeiri L, Possik E, Vijayaraghavan T, Paquette M, Martina JA, Kazan JM, Ma EH, Jones R, Blanchette P, Puertollano R, Pause A
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation.
Bott AJ, Peng IC, Fan Y, Faubert B, Zhao L, Li J, Neidler S, Sun Y, Jaber N, Krokowski D, Lu W, Pan JA, Powers S, Rabinowitz J, Hatzoglou M, Murphy DJ, Jones R, Wu S, Girnun G, Zong WX
10th international conference on AMPK: From mechanisms to new therapies
Principal investigators: Steinberg, Gregory R
Keywords: Aging; Cardiovascular Disease; Clinical Trials; Diabetes; Drug Development; Inflammation; Insulin Resistance; Metabolism; Obesity
Investigating the role of cellular metabolism in effector T cell responses and T cell exhaustion
Principal investigators: Roy, Dominic
Keywords: Cancer; Immunity; Infection; Metabolism; T Cell Exhaustion; T Cells
Investigating LKB1-mediated inflammation as a mediator of tumour progression
Principal investigators: Jones, Russell G
Keywords: Cancer; Cancer Metabolism; Gastrointestinal Polyps; Inflammation; Lkb1; Mtor; Peutz Jeghers Syndrome (Pjs); Stat3; T Cells; Tumour Suppressor
The Role of the Cellular Energy Sensor AMP-Activated Protein Kinase (AMPK) in Breast Cancer Metastasis and Chemoresistance
Principal investigators: Rabinovitch, Rebecca
Keywords: Ampk; Breast Cancer; Cancer; Chemoresistance; Chemotherapy; Metabolism; Metastasis; Mitochondria; Oncometabolism; P53
Metabolic Adaptations During Breast Cancer Metastasis
Principal investigators: Siegel, Peter M
Keywords: Breast Cancer; Metastasis; Tumor Metabolism; Tumor-Stromal Interactions
Investigating the regulation of lymphocyte function by metabolic reprogramming
Principal investigators: Jones, Russell G
Keywords: Amp-Activated Protein Kinase (Ampk); Animal Models; Cellular Metabolism; Inflammation; Listeria Monocytogenes; Metabolomics; Mitochondria; Signal Transduction; T Cells; T Lymphocyte Biology
Investigating the role of the immune system in the pathology of Peutz-Jeghers syndrome (PJS)
Principal investigators: Poffenberger, Maya C
Keywords: Cytokine; Gastrointestinal; Immunology; Inflammation; Lkb1; Metabolism; Mouse Model; Oncology; Peutz-Jeghers Syndrome; T Cell
Regulation of tumourigenesis and tumour cell metabolism by the energy sensor AMPK
Principal investigators: Jones, Russell G
Keywords: Amp-Activated Protein Kinase (Ampk); Apoptosis; Cancer Biology; Cellular Metabolism; Lymphoma; Metformin; Peutz-Jeghers Syndrome; Tumour Metabolism; Tumour Suppressors
AMPK: Mediating the Metabolic Switch In Warburg Metabolism
Principal investigators: Faubert, Brandon M
Keywords: Amp-Kinase; Gc/Ms; Glycolysis; Lkb1; Metabolism; Metformin; Nmr; Tca Cycle; Tumors; Western Blotting
Development of novel animal models to study the impact of metabolism on aging: Investigating the role of the AMP-activated protein kinase (AMPK)
Principal investigators: Jones, Russell G
Keywords: Aging; Amp-Activated Protein Kinase (Ampk); Animal Models Of Aging; Cellular Metabolism; Reactive Oxygen Species (Ros); Senescence; Tumour Suppression
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.